Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Current Treatment Options in Gastroenterology

Issue 2/2001

Content (11 Articles)

Treatment News

Obesity and liver disease

Ayman Koteish, Anna Mae Diehl

Treatment news bulletin

Hyperlipidemia in chronic cholestatic liver disease

Matteo Longo, Andrea Crosignani, Mauro Podda

Choledochal cystic diseases

Stephen D. Bruns, Thomas A. Broughan

Chronic visceral right upper quadrant pain without gallstones

Sanjeeb Shrestha, Pankaj J. Pasricha

Choledocholithiasis in the setting of portal hypertension

Yajaira Sierra, Irving Waxman

Bacterial cholangitis

Donald F. Lum, Joseph W. Leung

Small intestinal infections

Saurabh Mehandru, Edmund J. Bini

Portal hypertensive gastropathy and gastric antral vascular ectasia

Nelson Garcia Jr., Arun J. Sanyal

Vascular malformations of the small intestine

Umaprasana S. Karnam, Jamie S. Barkin

Gastric dysmotility and gastroparesis

Richard W. McCallum, Sabu J. George

Feb 01
Issue: 1/2001
Jun 01
Issue: 3/2001

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits